EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 11

Neem Azadirachta indica A.Juss.

Also called: margosa, Melia azadirachta (synonym)

Neem is a tree whose bark, leaves, flowers and seeds are used as food and in Ayurvedic medicine, and as a pesticide. Swallowing neem (margosa) oil has caused severe poisoning in children and adults, including seizures, coma and death.

Category
Botanical
Part used
Leaves, bark, flowers and seeds; neem (margosa) oil
Strongest evidence
C Limited
Native range
Native from Assam to Indo-China (POWO: "Assam to Indo-China")
Reviewed
2026-10-29

Class 2 Moderately studied in people. No review stating a count of oral trials was found. This entry cites 3 RCTs of oral neem leaf or leaf-and-twig extract alone versus placebo: sources 4, 10 and 11, in metabolic syndrome, type 2 diabetes and COVID-19 contacts. Mouthrinse trials (source 3) are separate. [4]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied4 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Neem does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Neem, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Dental plaque and gum inflammation (mouthrinses)CA 2021 review of 20 RCTs of herbal mouthrinses found neem among five herbs that outperformed chlorhexidine, but unclear risk of bias in most trials precluded definitive conclusions. [3]
Blood sugar in adults with metabolic syndromeCOne 12-week RCT (80 adults; 125-500 mg twice daily of a leaf-and-twig extract) reported dose-dependent improvements in fasting glucose, HbA1c and insulin resistance. [4]
Stomach acid secretionCA small study found neem bark extract reduced stomach acid secretion; MSK states more human studies are needed. [2]
CancerDOnly laboratory and animal studies exist; MSK states there are no human studies showing neem to be an effective cancer treatment. [2]

Main constituents: More than 140 compounds, including limonoids (e.g., azadirachtin, nimbolide, gedunin), flavonoids and phenolic acids, across all plant parts [1]; Nimbidin, from the seeds [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 125, 250 or 500 mg twice daily of an aqueous leaf-and-twig extract for 12 weeks (trial). [4]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    See details

    Ingestion of margosa oil has been linked to a Reye-like syndrome in children …

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    1 listed

    CYP3A4/5, CYP2C8 and CYP2C9 substrates

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Swallowing neem oil has caused severe poisoning in children and adults: vomiting, drowsiness, diarrhea, vision loss, acidotic breathing, encephalopathy and seizures with coma; deaths have occurred. [2]
  • A previously healthy 5-year-old who drank neem oil developed refractory seizures and metabolic acidosis, with later hearing and vision disturbances and ataxia. [5]
  • A Reye-like syndrome has been reported in children after margosa oil ingestion; in rats given the oil by intraperitoneal injection, it produced encephalopathy and fatty liver with mitochondrial damage. [6]
  • Topical use can cause allergic contact dermatitis. [2]
Interactions

Interactions

Known interactions of Neem
WithWhat happens
CYP3A4/5, CYP2C8 and CYP2C9 substratesA neem extract inhibited these enzymes in vitro; clinical relevance is not known. [2]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Regulation

Regulatory status

  • US: FDA states that, by law, it does not approve dietary supplements or their labeling; under DSHEA it has no authority to approve them before they are marketed, and firms are responsible for their products' safety and labeling. [7]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Azadirachtin, nimbolide, gedunin Limonoids (terpenoids) [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming neem (Azadirachta indica) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of neem (Azadirachta indica) or neem oil was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • Ingestion of margosa oil has been linked to a Reye-like syndrome in children; rats given the oil by intraperitoneal injection developed fatty liver with mitochondrial damage. [P4]

Interactions with medicines

  • CYP3A4/5, CYP2C8 and CYP2C9 substrates: A neem extract inhibited these enzymes in vitro; clinical relevance is not known. [P5]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component before use — 21 CFR 111.75(a)(1)(i) requires at least one appropriate identity test or examination unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 [P7]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Sharma A, et al. Ethnopharmacological landscape of Azadirachta indica (neem): phytochemical diversity bridging traditional heritage and modern medicine. J Ethnopharmacol 2026;371:122088 (PMID 42320775), 2026-12-06. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs on the Identification of Carcinogenic Hazards to Humans. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. Sinniah D, et al. Investigation of an animal model of a Reye-like syndrome caused by margosa oil. Pediatr Res 1985;19(12):1346-1355 (PMID 4080457), 1985-12. pubmed.ncbi.nlm.nih.gov
  5. Memorial Sloan Kettering Cancer Center. About Herbs: Neem (last updated April 11, 2023), 2023-04-11. mskcc.org
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, checked 2026-10-29), 2026-10-29. ecfr.gov
  7. GBIF species API: IUCN Red List category for Azadirachta indica, 2026-10-29. api.gbif.org
Sources

Sources

  1. Sharma A, et al. Ethnopharmacological landscape of Azadirachta indica (neem): phytochemical diversity bridging traditional heritage and modern medicine. J Ethnopharmacol 2026;371:122088 (PMID 42320775), 2026-12-06. pubmed.ncbi.nlm.nih.gov
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Neem (last updated April 11, 2023), 2023-04-11. mskcc.org
  3. Santi SS, et al. Effect of herbal mouthrinses on dental plaque formation and gingival inflammation: a systematic review. Oral Dis 2021;27(2):127-141 (PMID 31837279), 2021-03. pubmed.ncbi.nlm.nih.gov
  4. Pingali U, et al. Aqueous Azadirachta indica (neem) extract attenuates insulin resistance to improve glycemic control and endothelial function in subjects with metabolic syndrome. J Med Food 2021;24(11):1135-1144 (PMID 34582720), 2021-11. pubmed.ncbi.nlm.nih.gov
  5. Dhongade RK, Kavade SG, Damle RS. Neem oil poisoning. Indian Pediatr 2008;45(1):56-57 (PMID 18250509), 2008-01. pubmed.ncbi.nlm.nih.gov
  6. Sinniah D, et al. Investigation of an animal model of a Reye-like syndrome caused by margosa oil. Pediatr Res 1985;19(12):1346-1355 (PMID 4080457), 1985-12. pubmed.ncbi.nlm.nih.gov
  7. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  8. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Azadirachta indica A.Juss. (accessed 2026-10-29), 2026-10-29. powo.science.kew.org
  9. WCVP via GBIF species API: Melia azadirachta L., synonym of Azadirachta indica A.Juss. (retrieved 2026-10-29), 2026-10-29. api.gbif.org
  10. Pingali U, et al. Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus - A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Diabetes Metab Syndr Obes 2020;13:4401-4412 (PMID 33244247), 2020-11-17. pubmed.ncbi.nlm.nih.gov
  11. Nesari TM, et al. Neem (Azadirachta Indica A. Juss) Capsules for Prophylaxis of COVID-19 Infection: A Pilot, Double-Blind, Randomized Controlled Trial. Altern Ther Health Med 2021;27(S1):196-203 (PMID 33891569), 2021-10. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.